Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India

By on    Pharma Industry News  

Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India

Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart failure in India under the brand name Sacu V. According to Glenmark Pharmaceuticals, Sacu V should be taken daily two times under doctor’s prescription. The approved indication of sacubitril + valsartan tablets is for reduction of the […]

Novartis reveals positive results from Entresto Phase 4 TRANSITION study for heart failure patients

By on    Pharma Industry News  

Novartis reveals positive results from Entresto Phase 4 TRANSITION study for heart failure patients

Swiss pharmaceutical giant Novartis has announced encouraging results from the TRANSITION phase 4 clinical trial, affirming that Entresto (sacubitril/valsartan) can be safely initiated early in a broad range of patients with heart failure with reduced ejection fraction (HFrEF), shortly after stabilization from an acute heart failure episode. This groundbreaking study underlines the effectiveness of Entresto […]